JOURNAL OF CLINICAL ONCOLOGY

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

US

tipo

journal

publicação venue de

A DMBA-induced ovarian cancer model: Could it be clinically useful to test OncoTherad and erythropoietin as anticancer approaches?. 41:e17589-e17589. 2023-01-01
A real-world study of ALK fusion detection, treatment patterns, and survival outcomes of patients with advanced non-small-cell lung cancer (aNSCLC) in Brazil.. 41:e18655-e18655. 2023-01-01
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.. 41:TPS6111-TPS6111. 2023-01-01
Adjuvant therapy for HR+/HER2- early-stage breast cancer (EBC): Changes in practice patterns among community oncologists in Brazil.. 41:e18820-e18820. 2023-01-01
Association of primary tumor radiomic phenotypes and outcomes in patients (pts) with metastatic renal cell clear cell carcinoma (mRCC) treated with cytoreductive nephrectomy (CN).. 41:622-622. 2023-01-01
CD34 immunostaining for microvascular invasion analysis in hepatocelullar carcinoma.. 41:609-609. 2023-01-01
Cancer ontology understanding among community oncologists: Insights from a survey linked to implementation of mCODE-informed electronic health record (EHR).. 41:e18860-e18860. 2023-01-01
Cancer survival (SURVCANCER BRAZIL): Analysis of 132,621 cases from 19 hospital-based registries in southernmost Brazilian state comparing public and private insurance.. 41:6632-6632. 2023-01-01
Clinical and social importance of follow-up assessment of family members of patients with BRCA mutations.. 41:10621-10621. 2023-01-01
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial. 1:36795843. 2023-01-01
Effects of the coronavirus disease 2019 pandemic on anxiety and spirituality in patients with cancer undergoing chemotherapy: A cross-sectional study.. 41:e24200-e24200. 2023-01-01
Evaluation of the psychological state of patients suspected of Lynch syndrome after the germline genetic testing result.. 41:e24201-e24201. 2023-01-01
Exploring the significance of PARP inhibitor therapy after first-line chemotherapy in patients with homologous recombination proficient ovarian cancer: An extracted individual patient data and trial-level meta-analysis.. 41:5580-5580. 2023-01-01
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study. 41:1986-1991. 2023-01-01
Frequency and spectrum of CHEK2 variants in a large Brazilian set of germline-tested patients.. 41:e22539-e22539. 2023-01-01
High-dose chemotherapy with autologous stem cell transplant (HDCT) for patients (pts) with advanced germ-cell tumors (aGCT): Real-world evidence from a tertiary cancer center in Brazil.. 41:414-414. 2023-01-01
Impact of chemotherapy on anxiety, depression, and suicidality amongst testicular cancer survivors.. 41:418-418. 2023-01-01
Incidence of interstitial lung disease and cardiotoxicity with trastuzumab-deruxtecan in patients with breast cancer: A systematic review and single-arm meta-analysis.. 41:e13033-e13033. 2023-01-01
Maintenance therapy with a poly(ADP-ribose) polymerase inhibitor (PARP) in patients with newly diagnosed ovarian cancer: A systematic review and meta-analysis.. 41:e17587-e17587. 2023-01-01
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline. 1:1-8. 2023-01-01
Monoamine oxidase as a potential target for the development of new therapeutic strategies for bladder cancer.. 41:e16611-e16611. 2023-01-01
OncoTherad immunotherapy plus platelet rich plasma as potential therapeutic strategy for ovarian cancer: The role of toll-like receptors 2 and 4 signaling pathways.. 41:e17602-e17602. 2023-01-01
Oncology literacy: Educational book for children, families and health professionals.. 41:e24208-e24208. 2023-01-01
Optimization of protein extraction for proteomic analysis of formalin-fixed and paraffin-embedding (FFPE) biopsy specimens from males with breast cancer.. 41:e13119-e13119. 2023-01-01
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. 41:1600-1609. 2023-01-01
Prevalence and clinical correlations of Lynch syndrome (LS) in northeast Brazil.. 41:e22547-e22547. 2023-01-01
Sedentary lifestyle as a predictor of early death in older adults with cancer: A prospective cohort study with 2692 patients.. 41:12058-12058. 2023-01-01
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.. 41:8554-8554. 2023-01-01
The effect of exercise on physical function and medication adherence in women receiving endocrine therapy for breast cancer: The breast cancer endocrine therapy fitness (BE-FIT) randomized controlled trial.. 41:12069-12069. 2023-01-01
Time trend on breast cancer mortality: How are we allocating physicians to deal with the disease in men and women in Brazil?. 41:e22532-e22532. 2023-01-01
Use of the genetic signature of 70-genes MammaPrint in comparision with the immunohistochemical profile to de-escalate systemic treatment in the elderly population: Real-world study (AGEMA-BR).. 41:e12561-e12561. 2023-01-01
A biological network approach for mining target genes in EBV-positive gastric cancer.. 40:4056-4056. 2022-01-01
A real-world evidence of immunotherapy adoption in non-small cell lung cancer (NSCLC) treatment and its transition from platinum-refractory to the first line of therapy.. 40:e18714-e18714. 2022-01-01
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN.. 40:7539-7539. 2022-01-01
Anal Cancer: Emerging Standards in a Rare Rare Disease. 1:1. 2022-01-01
Association between TP53, PAR1 and CCR5 gene polymorphisms and non-small cell lung cancer susceptibility in the Amazon.. 40:NÃO-e20538. 2022-01-01
Cabozantinib (C) versus placebo (P) in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who have progressed after prior VEGFR-targeted therapy: Outcomes in prespecified subgroups based on prior VEGFR-targeted therapy.. 40:40. 2022-01-01
Cabozantinib versus placebo in patients (pts) with radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) who progressed after prior VEGFR-targeted therapy: Outcomes in prespecified subgroups based on histology subtypes.. 40:6081-6081. 2022-01-01
Characterization of patients with lung adenocarcinoma treated at a reference oncology center in northeastern Brazil and submitted to EGFR gene mutation research.. 40:e20548-e20548. 2022-01-01
Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. 41:132-142. 2022-01-01
Clinical and epidemiological features of penile squamous cell carcinoma according to pathological nodal stage in a Brazilian cancer reference hospital.. 40:e17017-e17017. 2022-01-01
Colorectal cancer mortality rates and socioeconomic factors in Brazil: Association with income inequality and availability of medical doctors.. 16:01-e22516. 2022-01-01
Crosstalk among T-cell CX3CR1, immune checkpoints and toll-like receptor 4 signaling pathway in BCG-unresponsive nonmuscle invasive bladder cancer: Mechanism of action of OncoTherad Nano-Immunotherapy.. 40:e16551-e16551. 2022-01-01
De-escalation of chemotherapy in elderly women using a 70-gene platform: Comparison of the MINDACT study with a real-world study in the Brazilian population (AGEMA-BRA).. 40:e12568-e12568. 2022-01-01
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study. x:x-x. 2022-01-01
Effects of anxiety and depression on the quality of life of male cancer patients undergoing genetic investigation for hereditary cancer predisposition syndromes.. 40:e22529-e22529. 2022-01-01
Evaluation of PD-1/PD-L1 and CTLA-4 immune checkpoints and angiogenic activity in ovarian cancer after oncotherad immunotherapy associated to erythropoietin.. 40:e17560-e17560. 2022-01-01
FLOT neoadjuvant therapy turns the expression patterns of cancer cells similar to those of non-cancer cells in gastric cancer patients.. 40:e16056-e16056. 2022-01-01
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study.. 40:1-1. 2022-01-01
Fusion Oncogenes Are Associated With Increased Metastatic Capacity and Persistent Disease in Pediatric Thyroid Cancers. 40:1081-1090. 2022-01-01
Genetic epidemiology of breast cancer (BC) risk genes from a diverse real-world oncology practice in Brazil.. 40:10594-10594. 2022-01-01
Giant Cell Tumor of Bone: Correlation between Immunohistochemical Expression of Metallo-Proteinases 9 with Clinical and Radiographic. 7:1-4. 2022-01-01
Identification of pharmacogenomic variants associated with oncology treatments in Brazilian Amazonian Amerindians.. 40:NÃO-e15082. 2022-01-01
Impact of histopathological revision and molecular pathology in the diagnosis of sarcomas in a reference center in Brazil.. 40:e23533-e23533. 2022-01-01
Impact of the COVID-19 pandemic on stage at diagnosis of patients with breast cancer: An analysis of 11,752 patients from Oncoclínicas.. 40:10559-10559. 2022-01-01
Implementation and first evaluation of a nationwide oncology navigation program.. 40:e13532-e13532. 2022-01-01
Inhibition of the mToR pathway with everolimus can modulate heat shock genes and ERCC1 gene expression and improves outcomes on serous ovarian cancer in HIPEC in vitro model. 40:1-7. 2022-01-01
Inhibition of the mToR pathway with everolimus can modulate heat shock genes and ERCC1 gene expression and improves outcomes on serous ovarian cancer in HIPEC model.. 40:e17541-e17541. 2022-01-01
International validation of the Immunoscore-biopsy (ISB) to guide selection and monitoring of patients treated with watch-and-wait (WW) strategy for rectal cancer. 50:00. 2022-01-01
Investigation of the DPYD, TYMS, ENOSF1, MTHFR, CDA, CES2, and UGT1A1 genes in patients who developed fatal fluoropyrimidine-associated toxicity in Northern Brazil.. 40:NÃO-e15532. 2022-01-01
Investigation of the DPYD, TYMS, ENOSF1, MTHFR, CDA, CES2, and UGT1A1 genes in patients who developed fatal fluoropyrimidine-associated toxicity in Northern Brazil.. 40:e15532-e15532. 2022-01-01
LungTS: A new gene expression signature for prediction of response to checkpoint inhibitors in non-small cell lung cancer.. 40:e21143-e21143. 2022-01-01
MUTYH-related polyposis syndrome associated with a variant of uncertain significance mutation: A new pathogenic mutation?. 40:e22528-e22528. 2022-01-01
Maintenance therapy following an anti-EGFR-based induction regimen in metastatic colorectal cancer (mCRC): A network meta-analysis of clinical trials.. 40:128-128. 2022-01-01
Malignant pleural mesothelioma in Brazil: An analysis of public databases between 2000 and 2017.. 40:e20597-e20597. 2022-01-01
Metastatic Rhabdomyosarcoma: Results of the European Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE Study. 40:3730-3740. 2022-01-01
Mucin (MUC) Family Influence on Acute Lymphoblastic Leukemia in Cancer and Non-Cancer Native American Populations from the Brazilian Amazon. 12:12-e19025. 2022-01-01
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651. .:.-.. 2022-01-01
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation-Sparing Approaches: An International Cohort Study. 41:1921. 2022-01-01
Ovarian cancer mortality: implications of income-inequality and availability of medical doctors in Brazil.. 40:e22520-e22520. 2022-01-01
PD-L1 expression and microsatellite instability in tumors of unknown primary site.. 40:2635-2635. 2022-01-01
PD-L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy. 126:150-160. 2022-01-01
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score. 40:35333599. 2022-01-01
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study. 40:JCO2102508. 2022-01-01
Randomized phase II trial of neoadjuvant androgen deprivation therapy plus abiraterone and apalutamide for patients with high-risk localized prostate cancer: Pathologic response and PSMA imaging correlates.. 40:5085-5085. 2022-01-01
Rare intrascrotal tumors in a tertiary cancer center: A retrospective case series.. 40:415-415. 2022-01-01
Real-world survival outcomes associated with use of pertuzumab and trastuzumab emtansine (T-DM1) for HER2-positive (HER2+) metastatic breast cancer (MBC) in Brazilian private healthcare setting.. 40:e13022-e13022. 2022-01-01
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). Feb:22. 2022-01-01
Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.. 40:5076-5076. 2022-01-01
The impact of face-to-face evaluation in the clinical assessment of cancer patients.. 40:e13651-e13651. 2022-01-01
Time-of-day infusion of immunotherapy may impact outcomes in advanced non-small cell lung cancer patients (NSCLC).. 40:e21126-e21126. 2022-01-01
Treatment patterns and outcomes of patients with metastatic colorectal cancer in third-line and beyond systemic therapy: Real-world data from a setting with limited resources.. 40:58-58. 2022-01-01
Updated safety and efficacy data from an open-label, phase 1/2 study of frontline brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine (A+AVD) in pediatric patients with advanced-stage classical Hodgkin lymphoma (cHL).. 40:10000-10000. 2022-01-01
18F-FDG-PET/CT response assessment in patients with advanced melanoma treated with combination of low-dose ipilimumab and anti-PD1: A real-world experience.. 39:e21533-e21533. 2021-01-01
A potential new therapeutic option for the treatment of nonmuscle invasive bladder cancer: Combination of intravesical oncotherad immunotherapy and platelet rich plasma (PRP).. 39:461-461. 2021-01-01
Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Elevate-TN four-year follow up.. 39:7509-7509. 2021-01-01
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. 39:1448-1457. 2021-01-01
Analysis of the effect of crossover from placebo (PBO) to darolutamide (DARO) on overall survival (OS) benefit in the ARAMIS Trial.. 39:240-240. 2021-01-01
Association of cytoplasmic HMGB1 (cHMGB1) expression with local tumor recurrence in triple-negative breast cancer.. 39:e12595-e12595. 2021-01-01
Clinical and immunological allergy assessment in cancer patients.. 11:18110-18118. 2021-01-01
Clinical-pathological characterization and outcomes of metastatic urothelial cancer in Latin America: Retrospective and translational multicenter database (LACOG 1518).. 39:TPS497-TPS497. 2021-01-01
Concrete case: An opportunity to improve cervical cancer prevention-Primary and secondary prevention of cervical cancer in patients with cervical cancer and their families.. 39:e18571-e18571. 2021-01-01
Deep learning algorithm performance in mammography screening: A systematic review and meta-analysis.. 39:e13553-e13553. 2021-01-01
Definitive chemoradiotherapy for squamous cell carcinoma of the anal canal (SCCAC) with cisplatin and capecitabine: A prospective cohort-preliminary results.. 39:e15506-e15506. 2021-01-01
Durable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia. 39:3352-3363. 2021-01-01
Efficacy and safety of PD-1 inhibitors as first- and second- line treatments for advanced gastroesophageal cancers: A network meta-analysis of phase III clinical trials. 39:e16032. 2021-01-01
Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. 39:66-78. 2021-01-01
Electronic patient reported outcome in Brazil: Insurance provider impact on adherence.. 39:#:e13590. 2021-01-01
Electronic patient reports outcomes and symptom monitoring for hematopoietic stem cell transplantation: A PILOT study.. 39:e13592-e13592. 2021-01-01
Expression of epidermal growth factor receptor (EGFR) in blood and tumor in patients with breast carcinoma: Prognostic analysis.. 39:e15013-e15013. 2021-01-01
Flow redesign to improve prostate cancer access and care at the public healthcare system in Sao Jose dos Campos, Brazil.. 39:e13595-e13595. 2021-01-01
Geolocation of uterine cervical neoplasms (UCN) in the context of a prevention program in Tucumán, Argentina.. 39:e13535-e13535. 2021-01-01
Health-related quality-of-life (HRQoL) analysis from a randomized phase II trial of androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.. 39:64-64. 2021-01-01
Identification and management of pathogenic mutations in and in a tumor-only genomic testing program.. 39:10528-10528. 2021-01-01
Impact of COVID-19 in the screening and treatment of breast cancer in the Brazilian public health system: Data from a healthcare data warehouse.. 39:e18807-e18807. 2021-01-01
Impact of COVID-19 pandemic in hospitalizations due to brain tumors from the epicenter of Latin America.. 39:03-e18785. 2021-01-01
Income-inequality and rate of doctors per inhabitant and their influence on esophageal cancer mortality in Brazil.. 21:01-e16089. 2021-01-01
Machine learning prediction of COVID-19 mortality in cancer patients.. 01:01-1558. 2021-01-01
Modulation of the RANK/RANKL/OPG system and FOXP3+ regulatory T cells in the tumor microenvironment of noninvasive bladder cancer after intravesical oncotherad immunotherapy associated with platelet-rich plasma.. 39:462-462. 2021-01-01
Multi-Institutional Validation of a Mammography-Based Breast Cancer Risk Model. 1:0:0-1740. 2021-01-01
Obinutuzumab short-duration infusion (SDI) in previously untreated advanced follicular lymphoma: Results from the end of induction analysis of the phase IV GAZELLE study.. 39:7545-7545. 2021-01-01
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial. 39:1518-1530. 2021-01-01
Prevalence of germline mutations in pancreatic carcinoma patients (PCP) unselected for family history (FH).. 39:e16263-e16263. 2021-01-01
Process redesign and daily management to improve cancer care access at the public healthcare system in Sao Jose dos Campos, Brazil.. 39:6530-6530. 2021-01-01
Proton pump inhibitors and antibiotics impact on toxicities and clinical outcomes in cancer patients treated with immunotherapy.. 39:2652-2652. 2021-01-01
Randomized study of electric hand warmer (EHW) versus observation to avoid discomfort during scalp cooling for chemotherapy-induced alopecia (CIA) prevention.. 39:12108-12108. 2021-01-01
Reduction in prostate cancer hospitalizations in the COVID-19 pandemic epicenter of Latin America.. 39:02-e18814. 2021-01-01
Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi. 39:1214-1222. 2021-01-01
Sociodemographic and clinicopathologic features of elderly breast cancer patients in Brazil: A sub-analysis of AMAZONA III study (GBCAM 0115).. 39:e12603-e12603. 2021-01-01
Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol.. 22:2463-2473. 2021-01-01
Upregulation of HSPB1 heat Shock gene and ERCC1 gene on Serous ovarian cancer cell line in HIPEC in vitro model. 39:e17559-e17559. 2021-01-01
Upregulation of HSPB1 heat shock gene and ERCC1 gene on serous ovarian cancer cell line in HIPEC in vitro model.. 39:e17559-e17559. 2021-01-01
A new PMS2 gene variant of unknown significance: How pathogenic is it?. 38:e13532-e13532. 2020-01-01
A retrospective evaluation of treatment decision making for thyroid cancer using clinical decision support in Brazil.. 38:e19193-e19193. 2020-01-01
Adjuvant systemic therapies for melanoma in Alberta: An early descriptive analysis of population characteristics and treatment outcomes. 38:e22013-e22013. 2020-01-01
Adjuvant therapy in non-metastatic melanoma result from a Brazilian cohort.. 38:e22095-e22095. 2020-01-01
Assessment of mutation burden after clinical intervention in pancreatic ductal adenocarcinomas (PDAC), and biliary tract cancers (BTC) via profiling circulating tumor DNA (ctDNA).. 38:e15529-e15529. 2020-01-01
Association of body mass index (BMI) with clinical efficacy of immune checkpoint inhibitors (ICI) in advanced cancer patients: A retrospective analysis.. 38:e15066. 2020-01-01
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study. x:JCO.19.02484. 2020-01-01
Axillary management after neoadjuvant chemotherapy in breast cancer: A survey by Brazilian Society of Mastology.. 38:e12609-e12609. 2020-01-01
Barriers identified in a patient navigation program for starting and completing definitive radiotherapy treatment in a limited resource setting.. 38:e19018-e19018. 2020-01-01
Bone metastasis as an independent prognostic factor for survival in patients with advanced melanoma treated with immune checkpoint blockade.. 38:e22045-e22045. 2020-01-01
CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).. 38:TPS9075-TPS9075. 2020-01-01
CD56 /CD16 NK-cell adoptive immunotherapy in patients with concurrent CNS disease and relapsed or refractory (R/R) AML.. 38:3025-3025. 2020-01-01
Cisplatin plus irinotecan versus cisplatin plus gemcitabine in the treatment of advanced or metastatic gallbladder or biliary tract cancer: Results of a randomized phase II trial (NCT01859728)- the Gambit trial.. 38:529-529. 2020-01-01
Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients. 27:JCO.20.00158. 2020-01-01
Clinicogenomic predictors of extreme responses to anti-PD1/PDL1 checkpoint inhibitors (CPI) in metastatic urothelial cancer (mUC).. 38:5050-5050. 2020-01-01
Combined OX40 agonist and PD-1 inhibitor immunotherapy improves the efficacy of vascular targeted photodynamic therapy in a urothelial tumor model.. 38:e17004-e17004. 2020-01-01
Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the U.K. Perspective.. 38:689-689. 2020-01-01
Could soluble levels of CD40L and galectin-9 be possible prognostic biomarkers and therapeutic targets in NSCLC?. 38:e21508-e21508. 2020-01-01
Discordant response comparing 18F-FDG PET/CT with response assessment by RECIST in patients with advanced melanoma treated with immune checkpoint blockade.. 38:10046-10046. 2020-01-01
Early referral to palliative care: Where are we in Brazil?. 38:e24118-e24118. 2020-01-01
Effect of adding bevacizumab to chemotherapy on pathologic response to preoperative systemic therapy of potentially resectable colorectal cancer liver metastases (CLM): A systematic review and meta-analysis.. 38:151-151. 2020-01-01
Effect of music therapy on symptoms, adverse events, and quality of life of breast cancer patients undergoing chemotherapy: A randomized clinical trial.. 38:e24140-e24140. 2020-01-01
Effects of alkaline water intake on gastritis and miRNA expression (miR-7, miR-155, miR-135b and miR-29c) in the Amazon population.. 12:4043-e16544. 2020-01-01
Efficacy and safety of immune checkpoint inhibitors (ICIs) in unresectable hepatocellular carcinoma (HCC): A systematic review and meta-analysis of randomized clinical trials (RCTs).. 38:e16631-e16631. 2020-01-01
Evaluation of a mobile cervical cancer screening program in São Luis, Maranhão, Brazil: Impact and challenges.. 38:1558-1558. 2020-01-01
Extension of bone marrow involvement and cytopenias in patients with metastatic castration-resistant prostate cancer (mCRPC).. 38:222-222. 2020-01-01
Extrapolation of indications and drug interchangeability as barriers to use trastuzumab-dkst biosimilar in Brazil.. 38:e13010-e13010. 2020-01-01
Factors related to the incidence of esophageal stenosis after treatment of advanced esophagus cancer. 38:suppl.e16561-suppl.e16561. 2020-01-01
Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK).. 38:10505-10505. 2020-01-01
Former smokers as the most frequent smoking status in patients with lung cancer in Brazil.. 38:e13597-e13597. 2020-01-01
Germline mutations in Brazilian pancreatic carcinoma patients.. 38:e16749-e16749. 2020-01-01
Human sperm cryopreservation prior cancer treatment: Follow up of 480 males for 23 years.. 38:15-15. 2020-01-01
Identifying the most vulnerable areas for the occurrence of new cases and deaths related to cervical cancer in the city of Recife, Brazil: See to act.. 38:e13628-e13628. 2020-01-01
Immune checkpoint inhibitors? (ICI) efficacy according to PD-L1 expression for advanced or metastatic NSCLC: Systematic review and meta-analysis.. 38:e21723-e21723. 2020-01-01
Impact of CD38 knockout in NK cells on daratumumab-mediated cytotoxicity and cellular metabolism.. 38:e15018-e15018. 2020-01-01
Impact of preoperative magnetic resonance imaging (MRI) on conservative surgery (CSur) among curable breast cancer (BC) patients treated in a specialized center in Latin America.. 38:e12595-e12595. 2020-01-01
Implementation of psychosocial support project in a pediatric oncology camping program.. 38:e22534-e22534. 2020-01-01
Independent validation of paige prostate: Assessing clinical benefit of an artificial intelligence tool within a digital diagnostic pathology laboratory workflow.. 38:e14076-e14076. 2020-01-01
KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).. 38:8005-8005. 2020-01-01
Mammographic screening and socio-epidemiological profile of Amerindian riverside women in the Amazon forest.. 38:e13573. 2020-01-01
Multidisciplinary tumor boards: A prospective study of the impact on patient management in a community-based Brazilian cancer center.. 38:e19261-e19261. 2020-01-01
Non-user physician perspectives about an oncology clinical decision-support system: A qualitative study.. 38:e14061-e14061. 2020-01-01
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR. 01:JCO.19.02408. 2020-01-01
Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial. 38:1164-1174. 2020-01-01
Oncotherad immunotherapy elicits promising responses in Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer: Results from phase I/ II study.. 38:e17048-e17048. 2020-01-01
OvarianTag biomarker panel in order guide treatment decisions cisplatin-based for women with epithelial ovarian cancer.. 38:e18075-e18075. 2020-01-01
PALB2</i> mutations in Brazilian patients from North-Northeast regions.. 38:e13670-e13670. 2020-01-01
Panorama of gynecological cancer in Brazil. 66:1617-1630. 2020-01-01
Pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for advanced breast cancer patients with high risk for Hereditary Breast and Ovarian Cancer Syndrome (HBOC).. 38:e13549-e13549. 2020-01-01
Pharmacogenetics findings in Brazilian cancer patients.. 38:e13607. 2020-01-01
Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415).. 38:5505-5505. 2020-01-01
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01). 38:203-213. 2020-01-01
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100. 01:JCO.20.00892. 2020-01-01
Pregnancy After Breast Cancer in Patients With Germline Mutations. 06/20:JCO.19.02399. 2020-01-01
Prevalence of germline mutations in BRCA 1/2 in patients from northeastern Brazil.. 38:e13603-e13603. 2020-01-01
Prevalence of pathogenic non- BRCA 1/2 gene variants in patients with suspected hereditary breast and ovarian cancer at a referral hospital in northeastern Brazil.. 38:e13602-e13602. 2020-01-01
Racial disparities in immune-related adverse events (irAE) of immune checkpoint inhibitors (ICPi) and association with survival based on clinical and biochemical responses.. 38:7025-7025. 2020-01-01
Real-world outcome with abiraterone low-dose plus prednisone in patients with mCRPC in a Brazilian Public Cancer Center.. 38:e17563-e17563. 2020-01-01
Retrospective analysis of intraoperative radiation therapy with low-kilovoltage x-rays (IORT-LK) in soft tissue sarcomas (STS).. 38:e23575-e23575. 2020-01-01
Role of patient navigation in improving access to radiotherapy treatment in a limited resource setting.. 38:e19019-e19019. 2020-01-01
SOLO 3 Trial: How Do the Results Fit in With Current Evidence?. 38:JCO.20.00576. 2020-01-01
Survival outcomes among older adults (OA) receiving second-line therapy for metastatic CRC (mCRC): 5,289 patients (pts) from the ARCAD Clinical Trials Program.. 38:7009-7009. 2020-01-01
Systematic review and meta-analysis of incremental cost-effectiveness ratio (ICER) for new cancer drugs.. 38:66-66. 2020-01-01
Trends in management and outcomes in patients with upper tract urothelial carcinoma following radical nephrouretectomy at Memorial Sloan Kettering Cancer Center.. 38:469-469. 2020-01-01
Using implementation science to examine impact of a social responsibility agenda on addressing cancer health disparities in Ceará, Brazil.. 38:e19071-e19071. 2020-01-01
mutations in Brazilian patients from North-Northeast regions.. 38:e13670-e13670. 2020-01-01

tem uma área de assunto

publisher

American Society of Clinical Oncology

is open access

False invalid format

is in DOAJ

False invalid format